Molbio Diagnostics Limited: Company Profile, Products, Careers & Job Opportunities

Molbio Diagnostics Limited is an Indian healthcare and molecular diagnostics company known for developing portable, point-of-care diagnostic technologies. The company’s flagship Truenat® platform has been designed to make molecular testing faster, more accessible and suitable for healthcare settings where conventional laboratory infrastructure may not be readily available.

Headquartered in Goa, India, Molbio has expanded from an Indian diagnostics innovator into a globally deployed healthcare technology company. Its solutions are now deployed across 90+ countries, with more than 12,500 Truenat® devices installed as of March 31, 2026, according to the company.

For professionals looking for opportunities in Quality Assurance, Quality Control, Production, R&D, Regulatory Affairs, Engineering, Sales, Service and other healthcare functions, Molbio is an important company to watch.

Molbio Diagnostics Limited – Company Overview

Molbio Diagnostics Limited was listed on the National Stock Exchange of India and Bombay Stock Exchange on 17 August 2026, marking a significant milestone in its growth journey.

History of Molbio Diagnostics

Molbio's journey began in 2000, when Sriram Natarajan founded Molbio in Goa. Around the same period, Dr. Chandrasekhar Nair established Bigtec Labs in Bengaluru with a focus on developing chip-based PCR technologies.

In 2011, Molbio and Bigtec joined forces through a 50:50 joint venture, combining Bigtec's PCR technology capabilities with Molbio's commercialization expertise.

The partnership eventually resulted in the development of the Truenat® platform, with the technology being deployed initially in Bihar to demonstrate how molecular diagnostics could be taken beyond centralized laboratories.

In 2015, Molbio Diagnostics and Bigtec Labs merged, with Bigtec becoming Molbio's dedicated R&D wing.

Over the following years, Truenat expanded into applications for diseases including tuberculosis, COVID-19, HIV, hepatitis, malaria and other infectious diseases.

What Does Molbio Diagnostics Do?

Molbio focuses on decentralizing molecular diagnostics.

Traditional molecular diagnostic testing can require centralized laboratories, specialized infrastructure and trained personnel. Molbio's approach is to bring molecular testing closer to the patient through portable and relatively easy-to-operate systems.

Its flagship Truenat platform combines:

• Trueprep AUTO V2 for automated sample preparation

• Truelab® real-time micro-PCR analyzers

• Truenat® disease-specific micro-PCR chips

• Software and systems for diagnostic workflows

According to Molbio, the platform is designed to provide molecular diagnostic results in approximately 60 minutes, depending on the workflow and test.

What is Truenat®?

Truenat® is Molbio's flagship multi-disease real-time PCR platform.

It is designed to be:

• Portable

• Battery-operated

• Fully automatic

• Suitable for decentralized testing

• Capable of testing multiple diseases

• Designed for minimal maintenance

• Usable in resource-limited healthcare environments

Molbio states that Truenat is patented in more than 100 countries and supports molecular testing across a broad range of diseases.

The platform has been used for testing related to diseases and conditions including:

• Tuberculosis

• COVID-19

• HIV

• Hepatitis B

• Hepatitis C

• Malaria

• Dengue

• Chikungunya

• Influenza

• HPV

• Cholera

• Leprosy

• HLA-B27 and other markers

The company's current portfolio includes more than 40 assays, while its September 2026 company update described 30 diseases covered through 43 assays.

How Does the Truenat Workflow Work?

One of the important features of the Truenat ecosystem is its integrated workflow.

Step 1 – Sample Collection

The appropriate patient sample is collected according to the diagnostic test being performed.

Step 2 – DNA/RNA Extraction

The sample is processed using the Trueprep AUTO V2 system.

Molbio states that the automated extraction and purification process takes approximately 20 minutes.

Step 3 – Real-Time PCR

The extracted nucleic acid is transferred to the Truelab® PCR Analyzer, where the target genetic material is amplified and detected using a disease-specific Truenat chip.

Step 4 – Result Reporting

Following PCR analysis, the system interprets the result and presents it to the operator.

Molbio describes the overall workflow as capable of delivering results in approximately 60 minutes.

Molbio and Tuberculosis Diagnosis

Tuberculosis has been one of the most important areas in Molbio's diagnostic journey.

The company's Truenat MTB-related assays have received recognition in global TB diagnostic guidance. WHO guidance has included Truenat MTB Plus and Truenat MTB-RIF Dx among low-complexity automated molecular assays for TB.

The Truenat platform was also incorporated into India's TB diagnostic ecosystem following multicentre validation and recommendations for its use in the National TB Elimination Programme.

This is particularly significant because molecular diagnostics can provide faster detection of tuberculosis compared with conventional approaches, while decentralized platforms can potentially bring testing closer to communities.

Molbio During the COVID-19 Pandemic

The COVID-19 pandemic demonstrated the importance of diagnostic technologies that can be deployed quickly.

According to Molbio's company history, Truenat adapted to COVID-19 testing, with the company's Truenat Beta CoV test receiving approval from ICMR during the pandemic.

Molbio states that more than 12 million gold-standard RT-PCR tests were conducted through Truenat during the COVID-19 response.

The experience highlighted one of the major advantages of the platform: its ability to adapt to emerging infectious disease requirements.

Global Presence

Molbio has expanded its international presence significantly.

The company currently states that its solutions are deployed in more than 90 countries, while its earlier milestones recorded deployment in more than 85 countries by 2024.

Molbio has also worked with international organizations and global health partners to expand access to molecular diagnostics in countries with significant disease burdens.

Its company website highlights collaborations involving organizations such as:

• Global Fund

• USAID

• Stop TB Partnership

• Other public-health and healthcare organizations

Through these collaborations, Truenat has been introduced into public-health programs in several high-burden countries.

Expansion Beyond Molecular Diagnostics

Molbio's business has expanded beyond the Truenat molecular diagnostics platform.

The company has entered additional healthcare technology areas through acquisitions, subsidiaries and strategic partnerships.

These include:

Digital X-Ray

Molbio acquired Prognosys Medical Systems, expanding its portfolio into portable AI-enabled digital X-ray technology.

Digital Pathology

Molbio holds a majority stake in OptraSCAN, a company focused on digital pathology and image analysis.

In 2026, OptraSCAN received US FDA 510(k) clearance for its OptraSCAN System, including the OS-Ultra Whole Slide Scanner and ImagePath Image Management Software with HER2 Image Analysis Software.

Breast Health Screening

Molbio has also collaborated with UE LifeSciences to market and distribute the iBreastExam® breast health screening device in developing markets.

This expansion indicates that Molbio's long-term strategy extends beyond a single diagnostic platform toward a broader healthcare technology ecosystem.

Quality and Regulatory Standards at Molbio

Quality is a critical function in the medical-device and diagnostics industry.

Molbio's official certificates and downloads section lists certifications and manufacturing licenses covering multiple products.

The company also lists an ISO 13485 certificate and MDSAP certificate, along with manufacturing licenses for several Truenat and related products.

For professionals working in Quality Assurance, Quality Control, Regulatory Affairs and manufacturing, this makes Molbio an interesting organization because diagnostic-device manufacturing involves strong requirements around:

• Quality Management Systems

• Design controls

• Process validation

• Risk management

• CAPA

• Deviations and non-conformances

• Change control

• Supplier quality

• Internal and external audits

• Regulatory compliance

• Product quality

• Manufacturing controls

• Documentation and traceability

Careers at Molbio Diagnostics

Molbio offers career opportunities across several functions.

Its official careers page describes the company as a team-oriented environment focused on innovation and healthcare impact.

Potential career areas include:

Quality Assurance

Professionals may find opportunities in areas such as:

• Quality Management Systems

• QA Operations

• Regulatory compliance

• Documentation

• CAPA

• Change control

• Audits

• Quality systems

Production

Production professionals can find opportunities related to:

• Medical-device manufacturing

• Diagnostic kit manufacturing

• Process operations

• Production planning

• Manufacturing controls

Research & Development

R&D is a major part of Molbio's business because the company continuously develops new diagnostic assays, platforms and healthcare technologies.

Regulatory Affairs

Regulatory professionals play an important role in ensuring diagnostic products comply with applicable regulatory requirements in India and international markets.

Engineering

Engineering teams support manufacturing equipment, automation, facilities, instrumentation and technology infrastructure.

Sales and Business Development

Because Molbio operates internationally, opportunities also exist in sales, application support, technical sales and business development.

Current Job Opportunities

Molbio's official careers portal publishes current openings.

At the time of writing, its careers page lists roles including Purchase Officer, Officer – Regulatory Affairs, and Officer – Sales and Administration (for Exports), with openings across locations/functions.

Because vacancies change frequently, candidates should always check the official Molbio careers page before applying rather than relying on old job-post screenshots or third-party listings.

Official Careers Page:
Molbio Diagnostics Careers

Who Can Apply for Molbio Jobs?

Eligibility depends on the specific position.

Depending on the role, Molbio may recruit candidates with educational backgrounds such as:

• B.Pharm

• M.Pharm

• B.Sc

• M.Sc

• Biotechnology

• Microbiology

• Biochemistry

• Biomedical sciences

• Engineering

• Electronics

• Electrical

• Mechanical

• Computer Science / IT

• Business Administration

• Finance and Accounts

• Supply Chain and Procurement

Experience requirements also vary considerably between positions.

Candidates should therefore check the exact job description before applying.

Why Molbio is an Interesting Company for Job Seekers

For candidates looking to build a career in diagnostics, medical devices or healthcare technology, Molbio offers exposure to a combination of disciplines.

The company operates at the intersection of:

Diagnostics + Biotechnology + Medical Devices + Molecular Biology + Manufacturing + Healthcare Technology

This can make the organization particularly relevant to candidates interested in building careers in modern healthcare manufacturing and diagnostics.

For QA and QC professionals, the combination of medical-device manufacturing, molecular diagnostics, regulatory requirements and quality systems can provide exposure to a specialized industry environment.

Molbio Diagnostics – Recent Milestone

One of the biggest recent milestones in Molbio's journey occurred in 2026, when Molbio Diagnostics Limited became a publicly listed company.

The company was listed on the BSE and NSE on 17 August 2026.

In its September 2026 update, Molbio said that the net proceeds from the listing were being deployed toward areas including automation capital expenditure and development of an R&D facility in Bengaluru.

This represents an important stage in the company's transition from a diagnostics startup and private company into a publicly listed healthcare technology organization.

What Makes Molbio Different?

The central idea behind Molbio's technology is decentralization.

Instead of requiring every molecular diagnostic test to be performed in a large centralized laboratory, portable systems can potentially bring testing closer to the patient.

This approach is particularly valuable in:

• Rural healthcare

• Primary healthcare centers

• Remote locations

• Mobile testing facilities

• Disease surveillance

• Outbreak response

• Resource-limited healthcare environments

Molbio describes its vision as creating diagnostic solutions that can overcome infrastructure limitations and provide actionable diagnostic information closer to where patients receive care.

Final Thoughts

Molbio Diagnostics Limited is one of India's notable companies in the point-of-care molecular diagnostics space.

Its flagship Truenat® platform has helped demonstrate how molecular testing can be moved beyond conventional centralized laboratories and into decentralized healthcare environments.

From its beginnings in Goa to its expansion across more than 90 countries, Molbio has built a business around the idea of making advanced diagnostics more accessible.

The company's expansion into digital X-ray, digital pathology and breast health screening also indicates a broader ambition to build an integrated healthcare technology portfolio.

For job seekers, Molbio can be particularly relevant for careers in Quality Assurance, Quality Control, Production, R&D, Regulatory Affairs, Engineering, Technical Support, Sales and other healthcare-related functions.

As the company continues to expand its products, international presence and R&D capabilities, Molbio is a company worth following for professionals interested in the diagnostics and medical-device industry.

Frequently Asked Questions

1. What is Molbio Diagnostics Limited?

Molbio Diagnostics Limited is an Indian healthcare technology and molecular diagnostics company headquartered in Goa. Its flagship product platform is Truenat®, a portable real-time PCR-based molecular diagnostic system.

2. What is Truenat®?

Truenat® is Molbio's portable, battery-operated real-time PCR platform designed for decentralized molecular diagnostics.

3. Where is Molbio Diagnostics headquartered?

Molbio Diagnostics is headquartered at Verna Industrial Estate in Goa, India.

4. Is Molbio Diagnostics a listed company?

Yes. Molbio Diagnostics Limited was listed on the NSE and BSE on 17 August 2026. Its NSE symbol is MOLBIO and its BSE code is 544866.

5. How can I apply for Molbio jobs?

Candidates can check current openings and apply through Molbio's official careers page.

Official Molbio Careers Page

6. What types of jobs are available at Molbio?

Depending on current vacancies, opportunities can include Quality Assurance, Regulatory Affairs, Production, Engineering, R&D, Sales, Administration, Procurement and other functions.

7. Is Molbio a pharmaceutical company?

Molbio is primarily a diagnostics and healthcare technology company, rather than a conventional pharmaceutical company. Its core expertise is molecular diagnostics and point-of-care diagnostic technology.

8. How many countries use Truenat?

Molbio currently states that its solutions are deployed in 90+ countries, with more than 12,500 Truenat devices installed as of March 31, 2026.

9. Is Truenat recognized by WHO?

Yes. WHO guidance has included Truenat MTB Plus and Truenat MTB-RIF Dx among low-complexity automated molecular assays for tuberculosis diagnosis.

10. Where can I find the latest Molbio vacancies?

The safest source is the company's official careers page because vacancies, locations and eligibility requirements can change.

Molbio Diagnostics – Careers

Disclaimer: This article is intended for informational and career-awareness purposes. Company information, job vacancies, products, regulatory status and business figures can change. Candidates should verify current vacancy details and other important information through Molbio Diagnostics Limited's official website and relevant official sources before making decisions.